Drugs / 5'Fluouracilo
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01454180 Comparator | Oct 2011 | exocrine pancreatic carcinoma | Spanish National Cancer Research Centre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5'Fluouracilo | “Oxaliplatin 85 mg/m2,irinotecan 180 mg/m2, folinic acid 400 mg/m2, 5'Fluouracilo 400 mg / m2, 5 'fluorouracil 2400 mg/m2 continuous intravenous infusion of 46 hours.” NCT01454180 ↗ |
| Route | Intravenous | “5 'fluorouracil 2400 mg/m2 continuous intravenous infusion of 46 hours.” NCT01454180 ↗ |